Curium US LLC
General
Total Cases2
Active Cases2
Patents48
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 10/18/24 | ENTRY of Appearance by Michael J. Kuhn for Plaintiffs Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications, SA. (Kuhn, Michael) (Entered: 10/18/2024) | |
| 10/18/24 | ENTRY of Appearance by Philip Allen Cantwell for Plaintiffs Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications, SA. (Cantwell, Philip) (Entered: 10/18/2024) | |
| 10/18/24 | ENTRY of Appearance by James F. Bennett for Plaintiffs Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications, SA. (Bennett, James) (Entered: 10/18/2024) | |
| 10/18/24 | DISCLOSURE STATEMENT by Advanced Accelerator Applications, SA, Novartis AG.. (Bennett, James) (Entered: 10/18/2024) | |
| 10/18/24 | DISCLOSURE STATEMENT by Advanced Accelerator Applications USA, Inc., Novartis AG.. (Bennett, James) (Entered: 10/18/2024) | |
| 10/18/24 | COMPLAINT against defendant Curium International Trading BV, Curium Netherlands BV, Curium US Holdings LLC, Curium US LLC with receipt number AMOEDC-10888523, in the amount of $405 Non-Jury Demand,, filed by Advanced Accelerator Applications USA, Inc., Advanced Accelerator Applications, SA. (Attachments: # [1] Exhibit Ex. A - Patent, # [2] Exhibit Ex. B - Patent, # [3] Exhibit Ex. C - Patent, # [4] Exhibit Ex. D - Article, # [5] Civil Cover Sheet Civil Cover Sheet, # [6] Original Filing Form Original Filing Form, # [7] Summons Curium US LLC, # [8] Summons Curium US Holdings LLC, # [9] Summons Curium Netherlands BV, # [10] Summons Curium International Trading BV)(Bennett, James) (Entered: 10/18/2024) | |
| 10/18/24 | Summons Issued as to Curium International Trading BV, Curium Netherlands BV, Curium US Holdings LLC, Curium US LLC. (Attachments: # [1] Summons Issued 2, # [2] Summons Issued 3, # [3] Summons Issued 4)(scs) (Entered: 10/18/2024) | |
| 10/18/24 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc. filed by Advanced Accelerator Applications SA, Advanced Accelerator Applications USA, Inc.. (scs) (Entered: 10/18/2024) | |
| 10/18/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,596,276; 10,596,278; 11,904,027. (scs) (Entered: 10/18/2024) | |
| 10/18/24 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/06/2024. Date of Expiration of Patent: 07/25/2038.Thirty Month Stay Deadline: 3/6/2027. (scs) (Entered: 10/18/2024) |